Summit's Integrated Wavefront Technology To Break In 2001
This article was originally published in The Gray Sheet
Executive Summary
Summit Technology, backed by encouraging results from 20 patients treated thus far in an ongoing feasibility trial, is hoping to market a customized refractive laser surgical system integrating the company's CustomCornea wavefront measuring device with its LADARVision system by the end of 2001.
You may also be interested in...
Genzyme Surgical Is Out Of General's Shadow Following January Run-up
Wall Street began to take note in January of Genzyme Surgical Products' leading position in the minimally invasive cardiac surgery market, as the stock price of the Genzyme General spin-off jumped 74.2%. The issue closed the month at 10-1/8, up 5-3/16.
LaserSight Views Pricing Options As Key To LaserScan Marketing Plan
LaserSight is highlighting its flexible payment and pricing scheme for its firm's LaserScan LSX ophthalmic excimer laser system as the firm gears up to compete with market leader Visx, with which it withdrew from patent licensing negotiations on Feb. 1.
Genzyme Surgical Is Out Of General's Shadow Following January Run-up
Wall Street began to take note in January of Genzyme Surgical Products' leading position in the minimally invasive cardiac surgery market, as the stock price of the Genzyme General spin-off jumped 74.2%. The issue closed the month at 10-1/8, up 5-3/16.